Support Alert

Class 4 drug alert (Caution in use) Actilyse 20mg and 50mg powder and solvent

24 Aug 2016
Class 4 drug alert (Caution in use) Actilyse 20mg and 50mg powder and solvent for solution 
 
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 drug alert for a specified batch of Actilyse 20mg and 50mg powder and solvent for solution manufactured by Boehringer Ingelheim Limited

Further details of the alert and action to take are available on the MHRA website.
 
Loading...